432
FRONT-LINE AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS: UNDERSTANDING THE REASONS FOR INELIGIBILITY AND ITS IMPACT IN SURVIVAL. REAL-WORLD PRACTICE IN A DEVELOPING COUNTRY
M.J. Atanazio, F.S. Seguro, H. Visnadi, P.E.D. Llacer, G.A. Martinez, V.G. Rocha
Universidade de São Paulo (USP), São Paulo, SP, Brazil
Lido
2251
Vezesque se leu este artigo
1131
Total PDF
1120
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 7 | 45 | 20 | 65 |
| 2025 6 | 47 | 19 | 66 |
| 2025 5 | 38 | 16 | 54 |
| 2025 4 | 34 | 12 | 46 |
| 2025 3 | 49 | 12 | 61 |
| 2025 2 | 41 | 16 | 57 |
| 2025 1 | 38 | 24 | 62 |
| 2024 12 | 27 | 13 | 40 |
| 2024 11 | 25 | 14 | 39 |
| 2024 10 | 30 | 24 | 54 |
| 2024 9 | 26 | 21 | 47 |
| 2024 8 | 31 | 27 | 58 |
| 2024 7 | 13 | 19 | 32 |
| 2024 6 | 22 | 21 | 43 |
| 2024 5 | 18 | 20 | 38 |
| 2024 4 | 18 | 19 | 37 |
| 2024 3 | 18 | 18 | 36 |
| 2024 2 | 15 | 22 | 37 |
| 2024 1 | 16 | 22 | 38 |
| 2023 12 | 15 | 23 | 38 |
| 2023 11 | 24 | 29 | 53 |
| 2023 10 | 13 | 27 | 40 |
| 2023 9 | 13 | 29 | 42 |
| 2023 8 | 8 | 16 | 24 |
| 2023 7 | 14 | 14 | 28 |
| 2023 6 | 16 | 15 | 31 |
| 2023 5 | 15 | 9 | 24 |
| 2023 4 | 12 | 7 | 19 |
| 2023 3 | 14 | 16 | 30 |
| 2023 2 | 10 | 13 | 23 |
| 2023 1 | 11 | 6 | 17 |
| 2022 12 | 14 | 20 | 34 |
| 2022 11 | 15 | 20 | 35 |
| 2022 10 | 20 | 25 | 45 |
| 2022 9 | 13 | 20 | 33 |
| 2022 8 | 14 | 22 | 36 |
| 2022 7 | 15 | 24 | 39 |
| 2022 6 | 12 | 23 | 35 |
| 2022 5 | 9 | 18 | 27 |
| 2022 4 | 9 | 30 | 39 |
| 2022 3 | 12 | 29 | 41 |
| 2022 2 | 15 | 23 | 38 |
| 2021 1 | 9 | 18 | 27 |
| 2021 12 | 13 | 16 | 29 |
| 2021 11 | 15 | 23 | 38 |
| 2021 10 | 19 | 28 | 47 |
| 2021 9 | 17 | 28 | 45 |
| 2021 8 | 17 | 28 | 45 |
| 2021 7 | 20 | 23 | 43 |
| 2021 6 | 16 | 18 | 34 |
| 2021 5 | 20 | 31 | 51 |
| 2021 4 | 39 | 27 | 66 |
| 2021 3 | 20 | 27 | 47 |
| 2021 2 | 12 | 11 | 23 |
| 2020 1 | 9 | 11 | 20 |
| 2020 12 | 12 | 10 | 22 |
| 2020 11 | 18 | 15 | 33 |
Mostrar tudo
